BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 20556793)

  • 1. Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection.
    Humphreys EH; Smith NA; Azman H; McLeod D; Rutherford GW
    Cochrane Database Syst Rev; 2010 Jun; (6):CD008563. PubMed ID: 20556793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micronutrient supplementation in children and adults with HIV infection.
    Irlam JH; Visser MM; Rollins NN; Siegfried N
    Cochrane Database Syst Rev; 2010 Dec; (12):CD003650. PubMed ID: 21154354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micronutrient supplementation for children with HIV infection.
    Irlam JH; Siegfried N; Visser ME; Rollins NC
    Cochrane Database Syst Rev; 2013 Oct; (10):CD010666. PubMed ID: 24114375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micronutrient supplementation in pregnant women with HIV infection.
    Siegfried N; Irlam JH; Visser ME; Rollins NN
    Cochrane Database Syst Rev; 2012 Mar; (3):CD009755. PubMed ID: 22419344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micronutrient supplementation in children and adults with HIV infection.
    Irlam JH; Visser ME; Rollins N; Siegfried N
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003650. PubMed ID: 16235333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection.
    Wiysonge CS; Shey MS; Sterne JA; Brocklehurst P
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003648. PubMed ID: 16235332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection.
    Shey WI; Brocklehurst P; Sterne JA
    Cochrane Database Syst Rev; 2002; (3):CD003648. PubMed ID: 12137702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age (Review).
    De-Regil LM; Suchdev PS; Vist GE; Walleser S; Peña-Rosas JP
    Evid Based Child Health; 2013 Jan; 8(1):112-201. PubMed ID: 23878126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.
    Imdad A; Mayo-Wilson E; Herzer K; Bhutta ZA
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD008524. PubMed ID: 28282701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection.
    Wiysonge CS; Shey M; Kongnyuy EJ; Sterne JA; Brocklehurst P
    Cochrane Database Syst Rev; 2011 Jan; (1):CD003648. PubMed ID: 21249656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of vitamins, including vitamin A, on HIV/AIDS patients.
    Mehta S; Fawzi W
    Vitam Horm; 2007; 75():355-83. PubMed ID: 17368322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years of age.
    Mayo-Wilson E; Junior JA; Imdad A; Dean S; Chan XH; Chan ES; Jaswal A; Bhutta ZA
    Cochrane Database Syst Rev; 2014 May; (5):CD009384. PubMed ID: 24826920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection.
    Grimwade K; Swingler GH
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD003508. PubMed ID: 16437457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole.
    Lin D; Li WK; Rieder MJ
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005646. PubMed ID: 17443608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routinely available cotrimoxazole prophylaxis and occurrence of respiratory and diarrhoeal morbidity in infants born to HIV-infected mothers in South Africa.
    Coutsoudis A; Pillay K; Spooner E; Coovadia HM; Pembrey L; Newell ML
    S Afr Med J; 2005 May; 95(5):339-45. PubMed ID: 15931449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of micronutrient supplementation on diarrhoeal disease among stunted children in rural South Africa.
    Chhagan MK; Van den Broeck J; Luabeya KK; Mpontshane N; Tucker KL; Bennish ML
    Eur J Clin Nutr; 2009 Jul; 63(7):850-7. PubMed ID: 19174830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled trial testing the effect of cotrimoxazole prophylaxis on morbidity and mortality outcomes in breastfed HIV-exposed uninfected infants: study protocol.
    Coutsoudis A; Daniels B; Moodley-Govender E; Ngomane N; Zako L; Spooner E; Kiepiela P; Reddy S; Kuhn L; Ramjee G
    BMJ Open; 2016 Jul; 6(7):e010656. PubMed ID: 27406638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin A supplementation for preventing morbidity and mortality in children from 6 months to 5 years of age.
    Imdad A; Herzer K; Mayo-Wilson E; Yakoob MY; Bhutta ZA
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008524. PubMed ID: 21154399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV.
    Grimwade K; Swingler ; G
    Cochrane Database Syst Rev; 2003; 2003(3):CD003108. PubMed ID: 12917946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.